Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


James R. Empfield, Wilmington US

James R. Empfield, Wilmington, DE US

Patent application numberDescriptionPublished
20080214570Therapeutic Agents - The present invention relates to compounds of formula I and processes for preparing such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods for their therapeutic use and to pharmaceutical compositions containing them.09-04-2008
20080227794Metabotropic Glutamate-Receptor-Potentiating Isoindolones - Compounds of formula I:09-18-2008
20080306087Therapeutic Agents - The present invention relates to compounds of formula (I) and processes for preparing such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods for their therapeutic use and to pharmaceutical compositions containing them.12-11-2008
20090062282Substituted Amino-Pyrimidones and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib below: (Ia, Ib), and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.03-05-2009
20090111830SUBSTITUTED ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS - The present invention is directed to compounds of formula I:04-30-2009
20090149505Metabotropic Glutamate Receptor-Potentiating Isoindolones - Compounds of Formula I:06-11-2009
20090221579Substituted Amino-Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib: Ia Ib and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.09-03-2009
20100317674Metabotropic Glutamate-Receptor-Potentiating Isoindolones - Compounds of formula I:12-16-2010
20110166155Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - The present invention is directed to compounds of formula I:07-07-2011

Patent applications by James R. Empfield, Wilmington, DE US